Codice QR

Almost Three Decades of Post-Marketing Experience With A Human Intravenous Immunoglobulin 5%: Analysis of A Proprietary Pharmacovigilance Database

Background: Intravenous immunoglobulin (IVIg) therapies are widely used for replacement and immunomodulatory indications but are associated with known risks of adverse drug reactions (ADRs), underscoring the importance of long-term, product-specific safety surveillance. Objective: This analysis eval...

Descrizione completa

Salvato in:
Autori principali: Davide Susini, MSc, Roberto Crea, DVM, MSc, Paolo Morabito, MD, Aaron Kleyn, PhD, Alessandro Bizzarri, MSc
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2026-06-01
Serie:Current Therapeutic Research
Soggetti:
Adverse drug reaction
Intravenous immunoglobulin
Pharmacovigilance
Post-marketing surveillance
Safety database
Accesso online:http://www.sciencedirect.com/science/article/pii/S0011393X2600007X
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi